News

Jasper Therapeutics: Upcoming Investor Conferences and Insights

Jasper Therapeutics: Upcoming Investor Conferences and Insights

Insights on Jasper Therapeutics' Upcoming Events

Jasper Therapeutics, Inc. (NASDAQ: JSPR) is making significant strides in the biotechnology sector as it approaches several key investor conferences. With a focus on briquilimab, an innovative antibody therapy designed to target c-Kit (CD117), Jasper is dedicated to tackling mast cell-driven diseases, including chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and asthma.

Details of the Investor Conferences

Stifel 2024 Healthcare Conference

The company is scheduled to attend the Stifel 2024 Healthcare Conference, slated for November 18–19. Jasper will be making a presentation on November 18 at 9:45 a.m. ET, utilizing a fireside chat format to engage with investors.

Jefferies London Healthcare Conference 2024

Following Stifel, Jasper will participate in the Jefferies London Healthcare Conference from November 19 to November 21. This conference provides a platform for Jasper to showcase its advancements to a broader audience, enhancing visibility within the investment community.

7th Annual Evercore ISI HealthCONx Conference

Additionally, Jasper will partake in the 7th Annual Evercore ISI HealthCONx Conference happening from December 3 to December 5. The company's presentation is scheduled for December 3 at 3:25 p.m. ET, also delivered in a fireside chat format.

Live Webcast Availability

For those unable to attend the conferences in person, Jasper will provide live webcasts of all presentations. These webcasts will be accessible through the Events & News section on Jasper's Investor Relations website. Moreover, archived replays of each presentation will be available for 30 days, ensuring that the telemetry of these discussions reaches a wider audience.

About Jasper Therapeutics

Jasper Therapeutics is at the forefront of developing briquilimab, a monoclonal antibody targeting c-Kit (CD117). This therapeutic is crafted to provide relief for chronic mast and stem cell diseases. Not only does briquilimab address chronic urticaria and asthma, but it also serves as a vital conditioning agent for stem cell transplants aimed at rare diseases such as sickle cell disease (SCD), Fanconi anemia (FA), and severe combined immunodeficiency (SCID).

Jasper's approach has already shown considerable results, with an established efficacy and safety profile in over 160 dosed participants and healthy volunteers. Remarkably, clinical outcomes in CIndU, SCID, acute myeloid leukemia, myelodysplastic syndromes, FA, and SCD highlight the immense potential of briquilimab.

Frequent Inquiries about Jasper Therapeutics

What is briquilimab?

Briquilimab is a monoclonal antibody developed by Jasper Therapeutics that targets c-Kit (CD117) to treat various mast cell-driven diseases, such as chronic urticaria and asthma.

When will Jasper present at investor conferences?

Jasper will present at multiple conferences, including the Stifel 2024 Healthcare Conference on November 18 and the Evercore ISI HealthCONx Conference on December 3.

Where can I find the live webcasts of the presentations?

Live webcasts of Jasper’s presentations can be found on the Events & News section of the company's Investor Relations website.

Is briquilimab approved for public use?

As of now, briquilimab is still in clinical development, demonstrating efficacy and safety through trials.

Who can I contact for more information about Jasper Therapeutics?

For investor inquiries, you can contact Joyce Allaire at LifeSci Advisors or Alex Gray at Jasper Therapeutics. Their contact information is available on the Investor Relations page.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ZKONG, Hagebau Push ESLs in European Retail Revamp

Updated Category News Views 81

ESLs: The Next Step in Retail Revamp Here’s the scoop: ZKONG and hagebau are making waves in the retail scene over in Germany. They’re bringing in Electronic Shelf Labels (ESLs) to kick traditional price tags to the curb. What started as a shake-up in supermarkets now rolls into the world of home improvement retail—headline by hagebaumarkt in Selb after nearly half...

Continue Reading
ATTACK SHARK's X60: A New Era in Gaming Audio

Updated Category News Views 38

Gaming Audio Gets a Power Boost with X60 We're diving headfirst into an era where gaming headsets promise more bells and whistles than ever before. This isn't just some random gadget plopped on the market. ATTACK SHARK's X60 Gaming Headset is strutting in, guns blazing, ready to take on the heavyweights in the competitive gaming world. It's not just about being another...

Continue Reading
HR HealthCare Foundation: New Chapter of Giving

Updated Category News Views 134

HR HealthCare Reaffirms Commitment Through New Foundation The corporate world didn't see this one coming. On October 29, 2026, HR HealthCare, a stalwart in the healthcare products arena, has decided to double down on its benevolent side by establishing the HR HealthCare Foundation. It ain't just about selling widgets anymore; it's about making a genuine impact outside the...

Continue Reading
Keith Strachan Elevates The Master Group's Strategy

Updated Category News Views 90

Strachan Steps Up as Chief Commercial Officer Keith Strachan is stepping into the role of Chief Commercial Officer at The Master Group—big news up in St-Bruno-de-Montarville. Now, those not neck-deep in HVAC-R might shrug this one off, but for those eyeing the industry, this is where the cards start to shuffle in North America. Master’s shift isn't just paper-pushing;...

Continue Reading
Kanazawa's Winter Crab Course Brings Flavor to Life

Updated Category News Views 24

An Unexpected Dance of Flavors Nestled in Kanazawa’s Nishi Chaya District, Canisienne Kanazawa isn’t just another eatery—it’s an engulfing dive into the world of winter crab extravagance. Picture yourself at an intimate, eight-seat counter, where chefs transform live crabs into culinary masterpieces right before your eyes. From early November to the end of...

Continue Reading
Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 181

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
FMC Corporation's Q3 2026: Tough Quarter, Dim Outlook

Updated Category News Views 24

FMC's Challenging Third Quarter Let's cut through the red tape right away—FMC Corporation just rolled out its Q3 2026 results, and boy, it wasn't pretty. Revenue plummeted to $106 million—a staggering drop from the $542 million of the same quarter last year. If you're wondering how such a bruising came about, you can thank the hefty commercial actions they pulled out...

Continue Reading
Gate's Strong Q3: Sales Growth & Rising Margins

Updated Category News Views 0

Solid Performance Boosts Confidence Gates Industrial came out swinging with their third-quarter results for 2026, showing some financial prowess that would make even the skeptics raise an eyebrow. Net sales climbed to a hefty $903.6 million, advancing 5.6% from the same time last year. It's not just smoke—core sales jumped 5.5%, signaling they're doing a bit more than...

Continue Reading
Wood Partners Expands Charlotte Footprint with New Project

Updated Category News Views 59

Charlotte's Expansion Beckons New Development at Village Park Charlotte's skyline is about to get a new neighbor in a growing district, as Wood Partners is set to break ground yet again, unveiling its ambitious plans for Village Park. This is not just a hodgepodge construction talk—it’s the company’s latest effort to plant its flag deep in the heart of the Queen...

Continue Reading
Ensign Group Faces Lawsuit: Investors Weigh Options

Updated Category News Views 11

Trouble Brewing for Ensign Group Investors There's no beating around the bush: The Ensign Group, Inc. (NASDAQ: ENSG) is caught up in a mess, and this isn't your run-of-the-mill kerfuffle. We've got a class action lawsuit on our hands, backed by the DJS Law Group. They’re not a bunch to take lightly; they’ve got experience with scalps in securities litigation. The...

Continue Reading